1. Home
  2. DERM

as 08-05-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SCOTTSDALE
Market Cap: 165.6M IPO Year: 2021
Target Price: $10.50 AVG Volume (30 days): 112.3K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.39 EPS Growth: N/A
52 Week Low/High: $3.54 - $8.25 Next Earning Date: 08-11-2025
Revenue: $56,243,000 Revenue Growth: -29.69%
Revenue Growth (this year): 28.99% Revenue Growth (next year): 52.61%

DERM Daily Stock ML Predictions

Share on Social Networks: